Developing bispecific antibodies for the treatment of immunological and inflammatory (I&I) disorders

Founded in 2024 by by Dr. Shanshan Xu and Helmut Jeggle, Bambusa Therapeutics is a rapidly growing biotechnology company specializing in developing transformative inflammatory and immunological therapeutics.

Based in the vibrant Boston Seaport area, our mission is to advance the field of immunology with cutting-edge solutions.

Our Team

We founded Bambusa Therapeutics with a belief that the I&I field is long overdue for innovative approaches and transformative therapeutics.

Since our inception, we have built a diverse portfolio of molecules and are uniquely positioned to make significant contributions to patients suffering from debilitating and chronic inflammatory conditions.

~ Shanshan Xu, MD, PhD

Chief Executive Officer and Founder